Related Experiment Videos

Prion protein is abnormally accumulated in inclusion-body myositis

V Askanas1, M Bilak, W K Engel

  • 1Department of Neurology, University of Southern California School of Medicine, Los Angeles 90017.

Neuroreport
|October 25, 1993
PubMed

Insights

Prion protein (PrP) was found in muscle fibers of inclusion-body myositis patients, co-localizing with beta-amyloid and ubiquitin. This suggests a potential role for PrP in the disease

Area of Science:

  • Neurology
  • Protein biochemistry
  • Muscle pathology

Background:

  • Inclusion-body myositis (IBM) is a progressive muscle-wasting disease.
  • The exact molecular mechanisms underlying IBM pathogenesis remain unclear.
  • Abnormal protein aggregation is a hallmark of many neurodegenerative diseases.

Purpose of the Study:

  • To investigate the presence and localization of prion protein (PrP) in muscle biopsies from patients with sporadic IBM (S-IBM) and hereditary IBM (H-IBM).
  • To determine the co-localization of PrP with other pathological markers like beta-amyloid (A beta) and ubiquitin (Ub) in IBM muscle fibers.
  • To explore the potential role of PrP in the pathogenesis of IBM.

Main Methods:

  • Analysis of muscle biopsies from 8 S-IBM and 4 H-IBM patients.
  • Immunohistochemistry using antibodies against PrP, A beta, and Ub.
  • Light and immuno-electron microscopy to visualize protein deposits and fibrils.

Main Results:

  • Vacuolated muscle fibers in IBM patients showed strong immunoreactivity for PrP.
  • PrP deposits co-localized with A beta and Ub in muscle fibers.
  • PrP and A beta were found on amorphous material and amyloid-like fibrils.
  • PrP and Ub were observed on cytoplasmic twisted tubulofilaments (TTFs).

Conclusions:

  • This study demonstrates abnormal accumulation of PrP in pathological tissue outside the brain for the first time.
  • The findings suggest that PrP may be involved in the pathogenesis of inclusion-body myositis.
  • PrP aggregation alongside A beta and Ub in muscle fibers highlights potential shared pathways in proteinopathies.

Related Concept Videos